Literature DB >> 33088314

Evaluation of cerebrospinal fluid and blood parameters finding in early diagnosis and drug therapy of suspected bacterial meningitis in neonates.

Huixian Li1, Rui Xiao2, Ruheena Javed1, Kuanrong Li1, Weitao Ye3, Wei Zhou4, Huiying Liang1.   

Abstract

BACKGROUND: Whether early lumbar puncture (LP) and blood indicators are suitable as diagnostic criteria and helpful to treatment strategies for newborns remains to be solved. The study was to evaluate the value of cerebrospinal fluid (CSF) at the first LP and blood indicators at the similar time in the early diagnosis and the drug therapy of neonatal bacterial meningitis.
MATERIALS AND METHODS: We conducted a retrospective observational study of 997 infants with suspected bacterial meningitis between June 2012 and June 2018. CSF and blood parameters were evaluated by three stepwise logistic models to assess their ability: to distinguish bacterial meningitis from nonbacterial meningitis, to distinguish positive CSF culture from negative, and to distinguish Gram-positive bacteria from negative.
RESULTS: Of the 997 neonates, 236 (23.67%) were later diagnosed as bacterial meningitis. Of the neonates with meningitis, 54 (22.88%) had positive CSF culture results. And of neonates with positive CSF culture, 27 (50%) had Gram-positive results. One or more CSF indicators were added to the three models. Only blood hypersensitive C-reactive protein and blood lactate dehydrogenase were added to the first model, while no blood parameters was added to the other two models. The areas under the effect-time curves of the three models were 0.91 (95% confidence interval [CI]: 0.89-0.92, P < 0.001), 0.69 (95% CI: 0.63-0.75, P < 0.001), and 0.86 (95% CI: 0.74-0.94, P < 0.001), respectively.
CONCLUSION: LP was irreplaceable predictor of bacterial meningitis, and comprehensive analysis of CSF indicators can predict the offending organism, which enables refinement of therapy. Copyright:
© 2020 Journal of Research in Medical Sciences.

Entities:  

Keywords:  Bacterial meningitis; cerebrospinal fluid; diagnosis; drug therapy; neonates

Year:  2020        PMID: 33088314      PMCID: PMC7554534          DOI: 10.4103/jrms.JRMS_470_19

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


INTRODUCTION

Neonatal bacterial meningitis is a rare but detrimental nervous system infection.[1] Mostly, it is a result of bacteremia and sepsis.[2] In developing countries, the annual incidence of bacterial meningitis is 0.2%–6.0% among live births and 1.4%~5% among preterm infants.[34] Meningitis is reported to be associated with increased neonatal mortality and morbidity and it may lead to a series of neurological sequelae in childhood, such as epileptic blindness, hearing impairment, cerebral palsy, mental retardation, autism, and so on.[5] Therefore, early diagnosis and prevention of neurologic complication after meningitis are critical.[6] Traditionally, the diagnosis of bacterial meningitis depends on examination of cerebrospinal fluid (CSF). However, the normal range of biochemical values of CSF in neonates is larger because of gestational age and birth weight.[7] CSF culture is considered the gold standard for diagnosis of bacterial meningitis, but the positive rate is low because of the use of antibiotics before lumbar puncture (LP).[8] Polymerase chain reaction is proved to be a promising test, but requires further study and adequate laboratory infrastructure.[910] A number of indicators such as hypersensitive C-reactive protein (hsCRP), lactate dehydrogenase (LDH), white blood cell count (WBCs), and glucose level in CSF have been proved to be valuable in the diagnosis of bacterial meningitis. The early detection of hsCRP, LDH, and WBCs is easier in the blood. However, complete blood cell count parameter had limited value in identifying neonatal bacterial meningitis.[11] There were a few studies that have evaluated some CSF indicators with blood indicators,[121314] and one study indicated that the serum procalcitonin (PCT) was the independent factor for bacterial etiology.[15] These studies would be limited by sample size and nonspecific inclusion criteria. This raises questions as to whether CSF at the first LP and blood parameters at the similar time are valuable in early diagnosis of neonatal bacterial meningitis and if these parameters can provide reference information for the drug therapy. In the present study, we retrospectively analyzed the level of hsCRP, LDH, and WBCs in both CSF and blood to evaluate their reference value in the early diagnosis and drug therapy of neonatal bacterial meningitis, and the value of glucose in CSF and PCT in blood was studied at the same time. All the indicators were derived from the first LP or the blood test at the similar time.

MATERIALS AND METHODS

Study design

The retrospective observational study patients were derived from the “Infection mediated brain injury specific disease cohort” (ChiCTR1800014597), which was conducted at the Guangzhou Women and Children's Medical Center, the largest tertiary class A referral pediatric hospital of Southern China. The study protocol was approved by the institutional ethics committee (Ethical approval number: 07600) and was carried out in accordance with the Declaration of Helsinki for experiments involving humans. The requirement to obtain informed consent was waived because of the retrospective nature of the study.

Participants

We collected data of 1138 infants with the inclusion criteria: (1) the neonates who underwent LP from June 2012 to June 2018; (2) age of diagnosis is ≤28 days from birth for full-term newborns, or <40 weeks postmenstrual age for premature infants. Patients with a history of traumatic brain injury, brain tumors, cerebral palsy, epilepsy, ventricular shunt, and neurosurgery (n = 128) or patients with more than 50% data loss (n = 13) were excluded.

Diagnostic criteria and classification criteria

Two senior doctors made a definite diagnosis based on the following clinical manifestations and laboratory test results: Meningitis: (1) Neonates with positive CSF culture; (2) neonates with negative CSF culture, but with abnormal CSF indicators, or/and with clear clinical manifestations. Nonmeningitis: Neonates with negative CSF culture and absence of clinical manifestations. Patients with meningitis and CSF culture results were grouped into two groups: positive CSF culture and negative CSF culture. Patients with positive CSF culture were also further grouped into two groups: Gram positive and Gram negative. The clinical manifestations of neonatal meningitis are often indistinguishable from those of neonatal sepsis without meningitis. The most frequently reported clinical manifestations are as follows: (1) unstable body temperature – anal temperature >38°C (fever) or <36°C (hypothermia); (2) nervous system manifestation – irritability, lethargy, hypotonia, tremor or twitching, and seizures;[16] (3) other manifestations – feeding difficulties/vomiting, respiratory distress (tachypnea, purr, alar agitation, three depression sign, and reduced breath sounds), apnea, and diarrhea.[1718]

Abnormal cerebrospinal fluid indicators

WBCs count >20 × 106/L, protein >1.5 g/L in the premature, protein >1.0 g/L in the full-term, glucose concentration lower than 50% of peripheral blood sugar, full-term glucose <1.7 mmol/L, or premature glucose <1.1 mmol/L.

Variables and measurement

The data of neonates with suspected bacterial meningitis who met the inclusion criteria, such as data on sex, gestational age, birth weight, age of onset, age of diagnosis, and results of the first LP of CSF and concurrent blood routine results, were derived from the clinical data repository. Tto reduce bias in the collection of information, another data analyst checked 5% of the data set against the original medical record data. According to the onset time of the bacterial meningitis, neonates were divided into early-onset infection (0–7 days after birth) and late-onset infection (8–28 days after birth).

Statistical analysis

Numeric variables were tested for normality using the Kolmogorov–Smirnov test. All the numeric variables were not normally distributed and were presented as the median (interquartile range). The categorical variables were presented as numbers (percentages). The differences between groups were compared with Mann–Whitney U-test for numeric variables and with Chi-square tests or Fisher's exact test for categorical variables. There were no missing data in the sex, gestational age, birth weight, and age of onset and age of diagnosis. The proportion of missing data of CSF and concurrent blood routine results was 0.6%–1.91% and we replaced the missing value with their median. Assessment of the diagnostic performance of hsCRP, LDH, WBCs, and glucose level in CSF and hsCRP, LDH, WBCs, and PCT level in blood was preceded in two steps. First, receiver operating characteristic (ROC) curve analysis and the area under the ROC curve (AUC) were used.[19] The optimal cutoff values for defining specific group were calculated by maximizing the sum of the sensitivity and specificity of each index. Second, all the collected variables were used in the stepwise logistic regression analyses with option SLENTRY = 0.20 and SLSTAY = 0.10 to determine the optimal combination for predicting the specific group. Comparison of the AUCs from ROC curve analysis was performed with Hanley tests. The selected variables in models were also presented with odds ratio [OR], 95% confidence interval [CI]. Power analysis was performed using NCSS PASS-11. All probability values were two-sided, and P < 0.05 was considered statistically significant. Analyses were performed using SAS 9.4 Windows software (SAS Institute, Inc., Cary, NC, USA, 2015).

RESULTS

Clinical characteristics and bacterial culture data

A total of 997 neonates who were suspected of neonatal meningitis and underwent LP, including 625 (62.69%) males and 372 (37.31%) females, were eventually included in the study. Among them, 761 (76.33%) neonates were diagnosed as nonmeningitis by doctors before discharge and 236 (23.67%) were diagnosed as bacterial meningitis. 836 (83.9%) neonates had antibiotics before underwent LP. Majority of the study subjects were full-term and normal-birth-weight neonates (68.30%). A total of 54 (22.88%) neonates with confirmed bacterial meningitis were positive in CSF culture, and out of them, 27 (50%) were Gram positive [Table 1].
Table 1

Baseline demographic characteristics and clinical groups

n (%)
Gender (n=997)
 Male625 (62.69)
 Female372 (37.31)
Gestational age (n=997)
 Preterm232 (23.27)
 Term765 (76.73)
Birth weight (n=997)
 LBW278 (27.88)
 NBW719 (72.12)
Group (n=997)
 Nonmeningitis761 (76.33)
 Meningitis236 (23.67)
Among meningitis (n=236)
 Early onset47 (19.92)
 Late onset189 (80.08)
Among meningitis (n=236)
 No culture result16 (6.78)
 Negative in CSF culture166 (70.34)
 Positive in CSF culture54 (22.88)
Among positive in CSF culture (n=54)
 Gram negative27 (50.00)
 Gram positive27 (50.00)

LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid

Baseline demographic characteristics and clinical groups LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid The top three common bacteria were Streptococcus agalactiae (Group B)(GBS) (n = 13), followed by Escherichia coli (n = 13) and Klebsiella pneumoniae (n = 4), which together accounted for 55.56% of the bacteria. The composition of bacterial pathogens is shown in Figure 1, and they differed with different characteristics except the gender. E. coli was mainly found in bacterial meningitis term and late-onset neonates, and K. pneumoniae was found in low-birth-weight (LBW), premature, and early-onset neonates. In addition, some bacteria such as Flavobacterium meningosepticum, Staphylococcus epidermidis, and Staphylococcus haemolyticus could be detected in normal-body-weight (NBW) and term neonates, which were lacking in LBW and premature neonates. The bacterial species in neonates with late-onset purulent meningitis was also more diverse than that in those with early-onset bacterial meningitis.
Figure 1

Distribution of bacterial pathogens detected in cerebrospinal fluid culture

Distribution of bacterial pathogens detected in cerebrospinal fluid culture

Distinguish meningitis from nonbacterial meningitis

All the CSF indicators showed statistically significant difference between bacterial meningitis patients and nonbacterial patients as presented in Supplementary Table 1, while among the blood indicators, a statistically significant difference was observed only for hsCRP and LDH but not for WBCs and PCT. The frequency of LBW was also significantly different between bacterial patients and nonpatients. Gender and gestational age showed no significant difference of distribution between the two groups. The areas under the effect-time curves (AUCs) of CSF indicators were 0.87 (95% CI: 0.85–0.89, P < 0.001), 0.84 (95% CI: 0.81–0.86, P < 0.001), 0.77 (95% CI: 0.74–0.79, P < 0.001), and 0.70 (95% CI: 0.67–0.73, P < 0.001) for WBCs, glucose, LDH, and hsCRP, respectively. For blood indicators, the AUCs were 0.64 (95% CI: 0.61–0.67, P < 0.001) for both hsCRP and LDH [Figure 2]. Stepwise logistic regression showed that the combination of the gender (OR = 0.60, 95% CI: 0.38–0.92, P = 0.021), birth weight (OR = 0.41, 95% CI: 0.25–0.67, P = 0.003), level of glucoses in CSF (OR = 0.18, 95% CI: 0.13–0.25, P < 0.001), count of WBCs in CSF (OR = 1.01, 95% CI: 1.00–1.01, P < 0.001), hsCRP level in blood (OR = 1.00, 95% CI: 1.00–1.01, P = 0.022), and LDH level in blood (OR = 1.00, 95% CI: 1.00–1.00, P = 0.006) had an AUC value 0.91 (95% CI: 0.89–0.92). The model showed a sensitivity of 52.97% and a specificity of 96.98% with the positive predictive value of 84.46% and negative predictive value of 86.93%.
Supplementary Table 1

Clinical characteristic for neonates by meningitis and nonmeningitis

Indicators, n (row %) or as shownNonmeningitis, (n=761)Meningitis (n=236)χ2/ZP
Gender
 Male468 (74.88)157 (25.12)1.950.16
 Female293 (78.76)79 (21.24)
Gestational age
 Preterm188 (81.03)44 (18.97)3.710.05
 Term573 (74.90)192 (25.10)
Birth weight
 LBW229 (82.37)49 (17.63)7.800.01
 NBW532 (73.99)187 (26.01)
CSF, median (IQR)
 hsCRP0.08 (0.01-0.29)0.40 (0.08-2.18)9.41<0.001
 LDH43 (33-58)85.5 (50-327)12.38<0.001
 WBC8 (3-10)100 (30-500)17.28<0.001
 Glucose2.55 (2.21-2.97)1.65 (0.76-2.12)−15.63<0.001
Blood, median (IQR)
 hsCRP3.21 (0.49-22.14)18.06 (1.74-81.70)6.68<0.001
 LDH416 (310-578)325 (259-450)−6.57<0.001
 WBC11.8 (8.9-16.0)12.8 (8.8-18.05)1.780.08
 PCT0.61 (0.17-8.20)0.50 (0.10-6.13)−1.480.14

LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid; LDH=Lactate dehydrogenase; WBC=White blood cell count; PCT=Procalcitonin; hsCRP=Hypersensitive C-reactive protein; IQR=Interquartile range

Figure 2

Cerebrospinal fluid and blood indicators' receiver operating characteristic curves for discriminating meningitis from nonmeningitis

Clinical characteristic for neonates by meningitis and nonmeningitis LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid; LDH=Lactate dehydrogenase; WBC=White blood cell count; PCT=Procalcitonin; hsCRP=Hypersensitive C-reactive protein; IQR=Interquartile range Cerebrospinal fluid and blood indicators' receiver operating characteristic curves for discriminating meningitis from nonmeningitis

Distinguish positive from negative in cerebrospinal fluid culture in confirmed bacterial meningitis

The distributions of gender, birth weight, gestational age, and age of onset were similar between positive CSF culture group and negative CSF culture group [Supplementary Table 2]. However, the levels of hsCRP in both blood and CSF in positive CSF culture group were significantly higher than those in the negative culture group. Furthermore, CSF glucose was statistically significantly lower in the positive CSF culture group than that in the negative group, while the results of other biochemical tests were similar in the two groups. There were only CSF hsCRP, blood hsCRP, and CSF glucose provided significant discriminatory information, with an AUC of 0.69 (95% CI: 0.63–0.75, P < 0.001), 0.65 (95% CI: 0.59–0.72, P < 0.001), and 0.59 (95% CI: 0.52–0.66, P = 0.034), respectively [Figure 3]. Stepwise binary logistic regression showed that only CSF hsCRP (OR = 1.23, 95% CI: 1.11–1.37, P < 0.001) was added to the model and the model had the same AUC of 0.69 (95% CI: 0.63–0.75, P < 0.001) as single CSF hsCRP do. The model showed a sensitivity of 20.37% and a specificity of 96.39% with the positive predictive value of 64.71% and negative predictive value of 78.82%.
Supplementary Table 2

Clinical characteristic for neonates by cerebrospinal fluid culture results

Indicators, n (row %) or as shownNegative (n=166)Positive (n=54)χ2/ZP
Gender
 Male113 (77.93)32 (22.07)1.410.24
 Female53 (70.67)22 (29.33)
Gestational age
 Preterm30 (73.17)11 (26.83)0.140.71
 Term136 (75.98)43 (26.83)
Birth weight
 LBW34 (72.34)13 (27.66)0.310.58
 NBW132 (76.30)41 (23.70)
Onset type
 Early onset34 (75.56)11 (24.44)0.000.99
 Late onset132 (75.43)43 (24.57)
CSF, median (IQR)
 hsCRP0.27 (0.07-1.19)1.79 (0.25-5.77)4.27<0.001
 LDH83 (51-252)236 (49-676)1.570.12
 WBC100 (32-330)160 (10-1340)1.420.16
 Glucose1.68 (1.02-2.1)1.27 (0.04-2.37)−2.010.05
Blood, median (IQR)
 hsCRP13.63 (1.45-54.73)70.95 (5.02-135.57)3.40<0.001
 LDH319.5 (253-449)330 (259-456)0.650.51
 WBC13 (9.5-17.1)11.5 (7.7-22.5)−0.430.67
 PCT0.5 (0.12-4.04)0.38 (0-10.96)−0.550.58

LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid; LDH=Lactate dehydrogenase; WBC=White blood cell count; PCT=Procalcitonin; hsCRP=Hypersensitive C-reactive protein; IQR=Interquartile range

Figure 3

Cerebrospinal fluid and blood indicators' receiver operating characteristic curves for discriminating positive cerebrospinal fluid culture from negative

Clinical characteristic for neonates by cerebrospinal fluid culture results LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid; LDH=Lactate dehydrogenase; WBC=White blood cell count; PCT=Procalcitonin; hsCRP=Hypersensitive C-reactive protein; IQR=Interquartile range Cerebrospinal fluid and blood indicators' receiver operating characteristic curves for discriminating positive cerebrospinal fluid culture from negative

Distinguish Gram positive from Gram negative in confirmed bacterial meningitis with positive cerebrospinal fluid culture

Distribution of Gram-positive bacteria and Gram-negative bacteria was similar in different gestational age and age of onset group. Male neonates and LBW had significantly higher proportion of Gram-negative cases than female and NBW (62.50% vs. 31.82%; 76.92% vs. 41.46%). Gram-positive group was significantly associated with lower CSF hsCRP and higher CSF glucose (all P < 0.05), while the other biochemical parameters were similar to the negative CSF culture group [Supplementary Table 3]. There were only CSF hsCRP and CSF glucose provided significant discriminatory information. CSF glucose had the similar diagnostic value in terms of predicting positive Gram's stain (AUC: 0.71, 95% CI: 0.57–0.83, P = 0.003) with CSF hsCRP (AUC: 0.68, 95% CI: 0.54–0.80, P = 0.015) [Figure 4]. Stepwise binary logistic regression analysis showed that only BW (OR = 0.02, 95% CI: 0.00–0.23, P = 0.002) and CSF glucose (OR = 4.34, 95% CI: 1.79–10.56, P = 0.001) were showed up into the model and the model had a c-statistic of 0.86 (95% CI: 0.74–0.94, P < 0.001). The model showed a sensitivity of 66.67% and a specificity of 88.89% with the positive predictive value of 85.71% and negative predictive value of 72.73%.
Supplementary Table 3

Clinical characteristic for neonates by Gram stain

Indicators, n (row %) or as shownGram negative (n=27)Gram positive (n=27)χ2/ZP
Gender
 Male20 (62.50)12 (37.50)4.910.03
 Female7 (31.82)15 (68.18)
Gestational age
 Preterm8 (72.73)3 (27.27)2.850.09
 Term19 (44.19)24 (55.81)
Birth weight
 LBW10 (76.92)3 (23.08)4.960.03
 NBW17 (41.46)24 (58.54)
Onset type
 Early onset4 (36.36)7 (63.64)1.030.31
 Late onset23 (53.49)20 (46.51)
CSF, median (IQR)
 hsCRP3.56 (0.41-10.78)1.53 (0.10-3.06)−2.230.03
 LDH266 (58-1560)80 (38-412)−1.840.07
 WBC190 (96-2330)130 (8-1010)−1.130.26
 Glucose0.15 (0.01-1.94)1.76 (0.34-2.62)2.650.01
Blood, median (IQR)
 hsCRP77.78 (14.80-183.70)57.92 (4.13-112.10)−0.740.46
 LDH329 (252-424)331 (259-488)0.450.65
 WBC13.2 (7.7-22.5)11.3 (6.9-19.6)0.090.93
 PCT1.65 (0-10.48)0.21 (0-25)−0.070.94

LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid; LDH=Lactate dehydrogenase; WBC=White blood cell count; PCT=Procalcitonin; hsCRP=Hypersensitive C-reactive protein; IQR=Interquartile range

Figure 4

Cerebrospinal fluid and blood indicators' receiver operating characteristic curves for discriminating Gram-positive from negative. Color should be used for all the four figures in print

Clinical characteristic for neonates by Gram stain LBW=Low birth weight; NBW=Normal birth weight; CSF=Cerebrospinal fluid; LDH=Lactate dehydrogenase; WBC=White blood cell count; PCT=Procalcitonin; hsCRP=Hypersensitive C-reactive protein; IQR=Interquartile range Cerebrospinal fluid and blood indicators' receiver operating characteristic curves for discriminating Gram-positive from negative. Color should be used for all the four figures in print

Power analysis

The value of AUC under the null hypothesis was 0.50, and the significance level (alpha) was 0.05 in the power analysis. The differences between null hypothesis and alternative hypothesis were tested by two-sided z-test. In classification model to distinguish bacterial meningitis from nonbacterial meningitis, a sample size of 997 (positive = 236, negative = 761) yields 100% power to detect a difference of 0.41 between the null hypothesis and the alternative hypothesis (AUC = 0.91). In classification model to distinguish positive CSF culture from negative, a sample size of 220 (positive = 54, negative = 166) yields 99% power to detect a difference of 0.19 between the null hypothesis and the alternative hypothesis (AUC = 0.69). In classification model to distinguish Gram-positive bacteria from negative, a sample size of 54 (positive = 27, negative = 27) yields 100% power to detect a difference of 0.36 between the null hypothesis and the alternative hypothesis (AUC = 0.86).

DISCUSSION

CSF culture remains to be the gold standard method for diagnosis of neonatal bacterial meningitis, while infants with bacterial meningitis had high intracranial pressure and were at high risk of herniation during LP.[20] Many doctors performed LP to reduce missed diagnosis even some of them are not required. In our study, we evaluated the value of CSF and blood indicators in the early diagnosis and the drug therapy of neonatal bacterial meningitis. The rate of positive CSF culture in the neonates with meningitis was 22.9%, which was consistent with Stoll et al.'s study (20%–30%).[21] In developed countries, early-onset infections are mainly caused by GBS, E. coli, and Listeria, while late-onset infections are mainly caused by Staphylococcus, G-bacillus, and GBS.[22] A French study including 363 children with meningococcal meningitis demonstrated that the infection rate of GBS was significantly higher than that of E. coli (59% vs. 28%), while the infection rate of E. coli was higher than that of GBS (45% vs. 32%) in premature infants and LBW infants.[23] Our study results showed no difference in pathogenic bacteria by sex. However, the diversity of pathogenic bacteria was more obvious in neonates with late-onset infections, whose main bacteria were E. coli and GBS. In early-onset cases, GBS was the main pathogenic bacteria. No E. coli was observed in premature infants, which may be a result of maternal antibiotics use. As an opportunistic pathogen, K. pneumoniae were found in premature, LBW, and early-onset infants. However, they were very rare in NBW and full-term infants. The difference may due to the former's immature immune system, weak neutrophil and monocyte phagocytosis, insufficient complement and antibody secretion.[24] In a meta-analysis in 2016, there was no significant difference between glycerol and dexamethasone in the prevention of neurologic complication after meningitis, irrespective of the cause.[6] However, dexamethasone may have different effects in bacterial meningitis caused by different pathogens. In our study, neonates in different groups had different pathogen compositions. It was important to identify pathogen before using dexamethasone in neonates.[25] Our model for distinguishing meningitis from nonmeningitis included sex, birth weight, and age at admission, level of glucoses and count of WBCs in CSF, hsCRP and LDH level in blood had an AUC of value 0.91. However, the overall missed diagnosis rate was 47.03% (the missed diagnosis rate was calculated by 100% minus the model's sensitivity), which suggests lower accuracy to correctly identify those with of bacterial meningitis, whereas specificity of 96.98% suggests higher accuracy to correctly identify those without the disease. It suggests that clinicians need to consider more objective indicators to improve the model's sensitivity. Chadwick et al.'s study found CSF WBCs >21 × 106/L as diagnostic criteria for BM, with a sensitivity of 79% and a specificity of 81%.[26] Our study showed that the cutoff value for WBCs was 29 × 106/L and the sensitivity was 75.4%, which is lower than other studies. It is hard to clearly diagnose the meningitis only based on LP results, and it often requires repeated puncture.[27] We further compared the first model in distinguishing nonbacterial meningitis from bacterial meningitis with single CSF WBCs. The △ AUC was 0.03 (95% CI, 0.00–0.07, P = 0.020), which suggested that there was only a limited improvement in diagnosis with combination of multiple indicators compared with single CSF WBCs. This was consistent with Huang et al.'s study.[28] As CSF culture positive rate was low, we emphasized to enucleate weather is there any indicator which could help indicate the positive culture rate. The overall missed diagnosis rate was 79.69% (100–20.31), and the overall accuracy was related to a lower level of 0.69. None of the factors except hsCRP in CSF we considered could improve the accuracy in distinguishing negative culture from positive culture cases, it may be related to small sample size of CSF culture positive cases which suggest to investigate the multi-center, large sample studies data to better understand the differences between positive and negative culture in the future. Early identification of Gram-negative or Gram-positive neonatal suppurative meningitis, selection of correct antibiotics, and early evaluation of prognosis are very important to reduce the sequelae of infants. The present study found that Gram-negative bacterial infections were more common in men and LBW infants, and CSF hsCRP increased significantly, and glucose levels in CSF decreased significantly. Our predicted model suggested the overall missed diagnosis rate 33.33% (100–66.67), the misdiagnosis rate 11.11% (100%–88.89%), and the overall accuracy 0.86, which suggested to be of good value to guide clinicians in early empirical drug therapy.

Limitations

There were some limitations of this study. First, as a retrospective cohort study, there was inevitable bias when collecting data and we only included the objective measures to reduce the recall bias. Second, glucose in blood and PCT in CSF were not routine tests and we could not adequately evaluate all the indicators in pairs. Third, only neonates who underwent LP were included and mild cases might be missed, which would cause an underestimate of the diagnostic cutoff values.

CONCLUSION

The testing of CSF in the prediction of neonatal bacterial meningitis is still irreplaceable. Early diagnosis and early pathogen identification of bacterial meningitis will contribute to personalized treatment of neonates with suspected meningitis in the early stage. More prospective research is needed to better explore the impacts of early diagnosis and early pathogen identification on prognosis.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  26 in total

1.  Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.

Authors:  Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

Review 2.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

3.  Comparison of Clinical Features and Prognostic Factors of Cryptococcal Meningitis Caused by Cryptococcus neoformans in Patients With and Without Pulmonary Nodules.

Authors:  Wenhao Cao; Cui Jian; Huojun Zhang; Shuyun Xu
Journal:  Mycopathologia       Date:  2018-05-08       Impact factor: 2.574

Review 4.  Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models.

Authors:  Kelly H Zou; A James O'Malley; Laura Mauri
Journal:  Circulation       Date:  2007-02-06       Impact factor: 29.690

5.  Traumatic lumbar punctures in neonates: test performance of the cerebrospinal fluid white blood cell count.

Authors:  Rachel G Greenberg; P Brian Smith; C Michael Cotten; M Anthony Moody; Reese H Clark; Daniel K Benjamin
Journal:  Pediatr Infect Dis J       Date:  2008-12       Impact factor: 2.129

6.  Progress and challenges in bacterial meningitis.

Authors:  Diederik van de Beek
Journal:  Lancet       Date:  2012-11-10       Impact factor: 79.321

Review 7.  Lumbar puncture in the neonate: challenges in decision making and interpretation.

Authors:  Lakshmi Srinivasan; Mary C Harris; Samir S Shah
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

8.  Management of suspected paediatric meningitis: a multicentre prospective cohort study.

Authors:  Roshan Ramasamy; Louise Willis; Seilesh Kadambari; Dominic F Kelly; Paul T Heath; Simon Nadel; Andrew J Pollard; Manish Sadarangani
Journal:  Arch Dis Child       Date:  2018-02-07       Impact factor: 3.791

9.  Early-onset group B streptococcal sepsis: a current assessment.

Authors:  L E Weisman; B J Stoll; D F Cruess; R T Hall; G B Merenstein; V G Hemming; G W Fischer
Journal:  J Pediatr       Date:  1992-09       Impact factor: 4.406

10.  Cerebrospinal fluid reference ranges in term and preterm infants in the neonatal intensive care unit.

Authors:  Lakshmi Srinivasan; Samir S Shah; Michael A Padula; Soraya Abbasi; Karin L McGowan; Mary C Harris
Journal:  J Pediatr       Date:  2012-05-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.